Vertex Pharmaceuticals Incorporated (VRTX) Booms on Cystic Fibrosis Combo Drug Study
4/23/2013
More...
|
Alkermes plc (ALKS) Has Jumped to a New High on Study Results
4/17/2013
More...
|
FDA Asks ACADIA Pharmaceuticals, Inc. (ACAD) to Skip Late Stage Study and File NDA After Successful Results
4/11/2013
More...
|
GlaxoSmithKline (GSK) Muscular Dystrophy Drug Reaches Primary Objective in Study
4/10/2013
More...
|
Liver Toxicity Brings Melanoma Study on Bristol-Myers Squibb Company (BMY)/Roche (RHHBY) Drugs to a Halt
4/4/2013
More...
|
Amgen (AMGN)'s Melanoma Drug Shows Promise in Key Trial
3/20/2013
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB)'s Injectable MS Drug Cut Relapse Rate by 36 Pct
3/20/2013
More...
|
Merck & Co., Inc. (MRK) Says a Crucial Vytorin Study Will Continue
3/13/2013
More...
|
Celgene Corporation (CELG)'s Apremilast Succeeds in Phase 3 Psoriasis Trial
3/5/2013
More...
|
FDA Halts Amgen (AMGN) Trial After Teen Death
3/4/2013
More...
|
AbbVie (ABBV) Suspends Five Clinical Trials of Leukemia Therapy After Patient Deaths
2/27/2013
More...
|
Genzyme Corporation (GENZ) Touts Positive Ph3 Drug Data
2/19/2013
More...
|
Gilead Sciences, Inc. (GILD) Sees Positive Results From Late-Stage Hepatitis C Treatment Study
2/19/2013
More...
|
Eli Lilly and Company (LLY) to Cease Tabalumab Phase 3 RA Program
2/8/2013
More...
|
Celsion Corporation (CLN)'s Plummets on Phase 3 Liver Cancer Failure
2/1/2013
More...
|
Pfizer Inc. (PFE) Reports Positive Results in Studies of Toviaz, Pristiq, Chantix
1/24/2013
More...
|
Celgene (CELG)'s Abraxane Keeps Pancreatic Pts Alive an Extra Two Months in Trial
1/24/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA)'s NUVIGIL® Fails Phase 3 Trial Again
1/23/2013
More...
|
Genentech (RHHBY) Takes Exelixis, Inc. (EXEL) Drug Into Phase III Melanoma Trial
1/22/2013
More...
|
The Medicines Company (MDCO) Jumps on Anti-Clotting Drug Study
1/9/2013
More...
|
Genentech (RHHBY) Preps for $100 Million Alzheimer's Trial
12/19/2012
More...
|
Oncolytics Biotech Inc. (ONC.TO) Soars on Positive Phase 3 Head and Neck Cancer Data
12/13/2012
More...
|
Celgene (CELG)'s Pomalidomide Helps in Myeloma After Others Fail
12/12/2012
More...
|
Stunning Data for Ambit Biosciences/Astellas Pharma Inc. (YPH.BE) AML Drug
12/11/2012
More...
|
Pfizer Inc. (PFE) New Breast Cancer Drug Heralded as Breakthrough
12/10/2012
More...
|
ViiV Healthcare Says Phase III Data From VIKING-3 Dolutegravir Study Encouraging
11/14/2012
More...
|
Johnson & Johnson (JNJ) Isn't Giving Up on Alzheimer Drug
11/13/2012
More...
|
Clavis Pharma ASA, Clovis Oncology (CLVS) Tank as Pancreatic Cancer Drug Fails Late-State Test
11/12/2012
More...
|
Amgen (AMGN) Drug Cuts Bad Cholesterol Up to 66 Pct in Patients - Trial
11/7/2012
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Hemophilia Drug Wows in Phase 3 Study
11/1/2012
More...
|
Bayer HealthCare (BAY)'s Lung Drug Shows Promise in Phase 3 Study
10/23/2012
More...
|
Pfizer Inc. (PFE) Kidney Cancer Drug Fails as Initial Treatment
10/18/2012
More...
|
Genentech (RHHBY)'s T-DM1 Stuns as Approval Creeps Up
10/10/2012
More...
|
Sanofi (France) (SAN.PA)'s Gaucher Pill Meets Goal in Phase 3 Trial
10/2/2012
More...
|
Pfizer Inc. (PFE)'s RA Drug Tofacitinib Tops Methotrexate in Phase III
9/18/2012
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Plummets on Pancreatic Cancer Drug Study Survival Results
9/17/2012
More...
|
Sanofi (France) (SAN.PA) Dengue Vaccine Less Effective Than Hoped
9/12/2012
More...
|
Roche (RHHBY) Ramps Up Alzheimer's Drug Trial as Rivals Stumble
9/11/2012
More...
|
Merck & Co., Inc. (MRK) Insomnia Drug Shows Positive Phase III Results
9/11/2012
More...
|
Bristol-Myers Squibb Company (BMY) Ends Hepatitis C Development After Patient Death; Eats a $1.8 Billion Loss
8/27/2012
More...
|
Idenix Pharmaceuticals, Inc. (IDIX) Hepatitis C Drug Put on Partial Hold
8/17/2012
More...
|
Roche (RHHBY) Says Avastin Slows Brain Cancer Tumor Growth
8/10/2012
More...
|
Amgen (AMGN) Halts Pancreatic Cancer Trial After Drug Failure
8/10/2012
More...
|
Pfizer Inc. (PFE), Johnson & Johnson (JNJ) Scrap Alzheimer's Drug After Phase III Study Fails
8/8/2012
More...
|
Roche (RHHBY) Moves Secret Heart Drug to Phase III Trial
7/25/2012
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB), Bayer AG (BAY.F) Drugs Fail to Slow MS Progression
7/19/2012
More...
|
Baxter International, Inc. (BAX) Alzheimer's Drug Keeps Four Patients Stable for 3 Years
7/19/2012
More...
|
Alnylam Pharmaceuticals (ALNY) Gains on Treatment Data for Deadly Nerve Disease
7/18/2012
More...
|
Merck & Co., Inc. (MRK) Bone Drug Shows Benefits So Trial is Stopped
7/16/2012
More...
|
Pfizer Inc. (PFE): Xalkori Improves Lung Cancer Patients' Survival in Phase III Trial
6/19/2012
More...
|
Bristol-Myers Squibb Company (BMY) Immune Drug Shows Promise in Three Cancers, Success May Spur Industry Race
6/5/2012
More...
|
Johnson & Johnson (JNJ) Prostate Cancer Drug So Effective Trial Stopped
6/5/2012
More...
|
ImmunoGen, Inc. (IMGN) Announces Development of Trastuzumab Emtansine for Early Stage HER2-Positive Breast Cancer
6/4/2012
More...
|
GlaxoSmithKline (GSK) Melanoma Drugs Beat Chemo in Pivotal Trials
6/4/2012
More...
|
Eli Lilly and Company (LLY)'s Diabetes Drug Meets Mid-stage Trial Goal
5/23/2012
More...
|
GlaxoSmithKline (GSK)'s Melanoma Cocktail Slows Cancer in Study
5/21/2012
More...
|
Boehringer Ingelheim Corporation Reports Convincing Data for Lung Cancer Therapy
5/17/2012
More...
|
Pfizer Inc. (PFE)'s Torisel Fails Phase III Renal Cell Carcinoma Study in Showdown Against Bayer HealthCare (BAY)'s Nexavar
5/16/2012
More...
|
Vertex Pharmaceuticals (MA) (VRTX) Soars as Cystic Fibrosis Drug Regimen Improves Patients’ Breathing
5/8/2012
More...
|
Gilead Sciences, Inc. (GILD)-Bristol-Myers Squibb Company (BMY)'s Experimental Hepatitis C Drug Cured 88% Post-Therapy
4/20/2012
More...
|
GlaxoSmithKline (GSK) to File GLP-1 Diabetes Drug Albiglutide as Data Impresses
4/4/2012
More...
|
Keryx Biopharmaceuticals (KERX), AEterna Zentaris (AEZS) Colorectal Cancer Drug Fails Trial
4/3/2012
More...
|
New Genentech (RHHBY) Breast Cancer Drug Shows Late Stage Trial Success
4/2/2012
More...
|
AVI BioPharma, Inc. (AVII): Eteplirsen Study Shows No Significant Improvement in Walking
4/2/2012
More...
|
AstraZeneca PLC (AZN), Targacept, Inc. (TRGT) Give Up on Antidepressant Drug After All Four Phase 3 Studies Fail
3/21/2012
More...
|
Omeros Corporation (OMER)' Eye Drug OMS302 Meets Phase 3 Clinical Trial Goal
3/14/2012
More...
|
Anthera Pharmaceuticals, Inc. (ANTH) Tanks as it Halts Phase III VISTA-16 Heart Drug Trial
3/13/2012
More...
|
Johnson & Johnson (JNJ)'s Zytiga Scores Big Win, Hurts Dendreon Corporation (DNDN), Helps Medivation, Inc. (MDVN)
3/9/2012
More...
|
Gilead Sciences, Inc. (GILD)’s Four-in-One AIDS Pill is Effective in Study
3/8/2012
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Soars on Positive Phase 2b Pancreatic Cancer Trial Results
2/22/2012
More...
|
Gilead Sciences, Inc. (GILD) Drops as Patients Relapse on Hepatitis C Drug
2/21/2012
More...
|
Actelion Ltd. (ALIOF.PK) CEO Says 120 Patients Died in Lung Drug Study
2/21/2012
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Inflammatory Bowel Disease Drug Meets Phase 3 Targets
2/21/2012
More...
|
Medivation, Inc. (MDVN) Soars as Prostate Cancer Drug is Well-tolerated in Phase 3 Trial
2/3/2012
More...
|
Bristol-Myers Squibb Company (BMY) Hepatitis C Pills Clear Virus Without Injections
1/20/2012
More...
|
Pfizer Inc. (PFE) Ditches $725 Million Medivation, Inc. (MDVN) Pact as Phase 3 Alzheimer Trial Disappoints
1/20/2012
More...
|
Bayer HealthCare (BAY)'s Colorectal Cancer Drug Regorafenib Shows Promise, Improves Overall Survival Rate by 29 Percent
1/18/2012
More...
|
Roche (RHHBY)'s Avastin Disappoints Against Ovarian Cancer
1/3/2012
More...
|
Study Challenges Bristol-Myers Squibb Company (BMY) on Bristol-Myers Squibb Company (BMY) and Sanofi (France) (SAN.PA)'s Plavix
12/29/2011
More...
|
Genentech (RHHBY)'s Two-Drug Strategy Raises the Bar in Breast Cancer, Positive Phase III Results Reported
12/9/2011
More...
|
Latest Data on Novartis AG (NVS) Afinitor Confirms Efficacy
12/9/2011
More...
|
GlaxoSmithKline (GSK) Drug Fails to Hit Goal in Breast Cancer Trial
12/9/2011
More...
|
Gilead Sciences, Inc. (GILD)'s Cobicistat Shows Efficacy in Phase 3 Study
12/7/2011
More...
|
Regeneron Pharmaceuticals, Inc. (REGN)-Bayer HealthCare (BAY) Drug Matches Lucentis at 2 Years in Fewer Doses
12/6/2011
More...
|
Genzyme Corporation (GENZ) MS Drug Significantly Reduces Relapse, Disability in Phase III Trial
11/15/2011
More...
|
Eli Lilly and Company (LLY) Experimental Drug Doubles Good Cholesterol in Race With Merck & Co., Inc. (MRK), Roche (RHHBY)
11/15/2011
More...
|
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE) Clot Drug Fails to Help Ill Patients
11/15/2011
More...
|
Roche (RHHBY)'s New MS Drug "Cuts Relapses by 80 Percent" in Phase 2 Trial
11/4/2011
More...
|
Shire plc Soars on Positive Phase 3 Prostate Cancer Data
11/4/2011
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB)'s Oral MS Drug Shines in Phase 3 Study
10/24/2011
More...
|
GlaxoSmithKline (GSK)'s Malaria Vaccine Works in Major Trial
10/21/2011
More...
|
Teva Pharmaceutical Industries Limited (TEVA) and Active Biotech AB (BTPC) Laquinimod Trial for MS Treatment Yields Positive Results
10/20/2011
More...
|
Halozyme Therapeutics, Inc. (HALO) Announces Positive Results from Roche (RHHBY)'s Subcutaneous Herceptin Phase 3 Trial
10/19/2011
More...
|
Merck & Co., Inc. (MRK)'s ISENTRESS(R) (raltegravir) in Combination Therapy Shows Benefits Over Efavirenz
10/13/2011
More...
|
VA Halts Roche (RHHBY)'s Avastin for Eye Disease; Rival Regeneron Pharmaceuticals, Inc. (REGN)'s Stock Surges
9/23/2011
More...
|
Gilead Sciences, Inc. (GILD) Bumps Up Filing Timeline for Quad Pill, HIV Med Outperforms Rival in Study
9/21/2011
More...
|
Nektar Therapeutics (CA) (NKTR) Release: Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the American Society of Clinical Oncology 2011 Breast Cancer Symposium
9/12/2011
More...
|
Pfizer Inc. (PFE)'s Arthritis Pill Tofacitinib Matches Abbott Laboratories (ABT)'s Humira in Final Studies
9/9/2011
More...
|
AstraZeneca PLC (AZN)'s Crestor Fails to Beat Pfizer Inc. (PFE)'s Lipitor
9/6/2011
More...
|
Amgen (AMGN), Cytokinetics, Inc. (CYTK) Heart Failure Class Shows Promise in Phase II
8/22/2011
More...
|
Endo Pharmaceuticals (ENDP) Terminates Pain Program After Failed Trial; Ends Pact With Grunenthal GmbH
8/19/2011
More...
|
Topline Results for GlaxoSmithKline (GSK)'s Second Phase III Parkinson's Drug Study
8/16/2011
More...
|
Gilead Sciences, Inc. (GILD)'s Quad JOV Drug Shows Positive Results in Phase III Trial
8/15/2011
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) and Abbott Laboratories (ABT) Report Top-Line Positive Results for Daclizumab HYP Trial in RRMS
8/10/2011
More...
|
GlaxoSmithKline (GSK)-Pfizer Inc. (PFE) AIDS Pill May Dislodge Bristol-Myers Squibb Company (BMY)'s, Study Suggests
7/28/2011
More...
|
Genentech (RHHBY) Drug Impresses in Phase III Trial; to Seek Approval by Year End
7/27/2011
More...
|
Amylin Pharmaceuticals, Inc. (AMLN), Alkermes (ALKS) Shares Jump on Success in Bydureon Study
7/27/2011
More...
|
Sanofi (France) (SASY.PA)/Regeneron Pharmaceuticals, Inc. (REGN)'s Sarilumab Shines for Rheumatoid Arthritis, Fails in Ankylosing Spondylitis in Phase 2b Trial
7/27/2011
More...
|
Nabi Biopharmaceuticals (NABI) Shares Plunge After Smoke-Cessation Drug Shown Ineffective in Study
7/19/2011
More...
|
Vertex Pharmaceuticals (MA) (VRTX) Slides as Cystic Fibrosis Drug Shows Promise but Also Raises Questions in Phase II Trial
6/30/2011
More...
|
Roche (RHHBY) Melanoma Drug Cuts Risk Of Death By 63 Percent; Bests Bristol-Myers Squibb Company (BMY) In Study
6/29/2011
More...
|
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE) Blood Thinner Tops Warfarin in Stroke Study, Wows Investors
6/29/2011
More...
|
Pfizer Inc. (PFE) Lung Cancer Pill May Double Survival
6/29/2011
More...
|
Exelixis, Inc. (EXEL) Drug Slows Prostate Cancer Spread In Trial But Also Reports Deaths in Study
6/8/2011
More...
|
Pfizer Inc. (PFE) Presents New Phase 3 Data Showing Axitinib Significantly Extended Progression-Free Survival Compared With Sorafenib In Patients With Previously-Treated Advanced Renal Cell Carcinoma
5/19/2011
More...
|
Pfizer Inc. (PFE) Lung Cancer Drug Shows Survival Benefit
5/18/2011
More...
|
Pearl Therapeutics' Phase IIb Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva(R) and Foradil(R) in Patients with COPD
5/18/2011
More...
|
Amgen (AMGN)'s XGEVA Phase 3 Trial Meets Primary Endpoint
5/18/2011
More...
|
New Study Reveals Risks with Roche (RHHBY)’s Avastin for Wet AMD Versus Novartis AG's Lucentis
5/5/2011
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Shares Soar on Multiple Sclerosis Drug Data
4/22/2011
More...
|
Amgen (AMGN) and UCB, Inc. (UCBJF.PK) Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
4/21/2011
More...
|
Novartis AG, Sosei Co., Ltd. COPD Drug Phase III Trial Meets Primary Endpoint
4/19/2011
More...
|
Amarin Corporation PLC (AMRN)'s Late-stage AMR101 Study Meets Key Goals In Mixed Dyslipidemia Patients
4/18/2011
More...
|
Phase III Clinical Trial of Gilead Sciences, Inc. (GILD)’s Investigational Elvitegravir Meets 48-Week Primary Objective
3/23/2011
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (France) (SAN.PA) Cancer Drug Misses Phase III Primary Endpoint but Meets Secondary Targets
3/14/2011
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) Exenatide Once Monthly Showed Positive Results in Phase 2 Study
3/10/2011
More...
|
Eli Lilly and Company (LLY), Amylin Pharmaceuticals, Inc. (AMLN) and Alkermes plc (ALKS)' Bydureon Fails Against {4}'s Victoza in Head to Head Study
3/3/2011
More...
|
Regeneron Pharmaceuticals, Inc. (REGN)'s ARCALYST(R) (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy
2/28/2011
More...
|
Exelixis, Inc. (EXEL) Cabozantinib (XL184) Phase 2 Data Demonstrate Encouraging Clinical Activity in Patients with Castration-Resistant Prostate Cancer
2/18/2011
More...
|
Renovo Group Plc (RNVO.L) Falls As Juvista Fails In Clinical Trial
2/11/2011
More...
|
Idenix Pharmaceuticals, Inc. (IDIX) Cancels Hepatitis C Drug On Toxicity Worries; Shares Fall
2/10/2011
More...
|
Genentech (RHHBY): Third Phase III Study of Avastin-Based Regimen Met Primary Endpoint in Ovarian Cancer
2/8/2011
More...
|
Optimer Pharmaceuticals, Inc. (OPTR) Antibiotic Cuts Recurrence of Deadly Bacteria
2/3/2011
More...
|
Chelsea Therapeutics, Inc. (CHTP) Announces Interim Results and Plans to Modify Study 306 to Focus on Reduction in Falls Associated With Neurogenic Orthostatic Hypotension
2/2/2011
More...
|
Merck & Co., Inc. (MRK) Says Clot Preventer has Bleeding Risk
1/20/2011
More...
|
Targacept, Inc. (TRGT) Announces Positive Top-Line Results from Phase 2 Trial of TC-5619 in Cognitive Dysfunction in Schizophrenia
1/19/2011
More...
|
Plexxikon Inc., Roche Holding AG (RHHBF.PK) Report Overall Survival Benefit for Melanoma Patients in PLX4032 Phase 3 Trial
1/19/2011
More...
|
Ariad Pharmaceuticals, Inc. (ARIA)'s Drug Ridaforolimus Meets Main Goal In Phase III Trial Of Bone Sarcomas
1/18/2011
More...
|
Lexicon Pharmaceuticals, Inc. (LXRX) Shares Jump on Positive Diabetes Study Results
1/7/2011
More...
|
Teva Pharmaceutical Industries Limited (TEVA)/Active Biotech AB's MS Pill Shines in Phase III Study
12/9/2010
More...
|
Onyx Pharmaceuticals, Inc. (ONXX) Drug Carfilzomib Reduces Cancer in a Third of Patients With Deadly Blood Cancer in Phase 2 Study; Raising Stakes in Rivalry with Millennium: The Takeda Oncology Company
12/8/2010
More...
|
Seattle Genetics, Inc. (SGEN) and Millennium: The Takeda Oncology Company's Experimental Drug, SGN-35 Shrinks Hodgkin's Tumors, Study Shows
12/7/2010
More...
|
Pfizer Inc. (PFE)'s Investigational Compound Bosutinib Fails to Meet Primary Endpoint in Phase 3 Study For Chronic Myeloid Leukemia
12/7/2010
More...
|
Amarin Corporation PLC (AMRN) Omega-3 Drug, AMR101, Lowers Blood-Fat Levels in Clinical Trial; Stock Rises; Drug Will Be Submitted for FDA Approval Earlier Than Expected
11/30/2010
More...
|
Next Big Thing? Big Cholesterol Drop with New Drug, Anacetrapib from Merck & Co., Inc. (MRK) in Phase III Study
11/17/2010
More...
|
Johnson & Johnson (JNJ): Rivaroxaban Significantly Reduces Risk of Stroke in Patients With Atrial Fibrillation With Comparable Safety vs. Warfarin in Pivotal Phase 3 Study
11/15/2010
More...
|
Pfizer Inc. (PFE) Heart-Failure Drug, Inspra Helps Milder Patients
11/15/2010
More...
|
Rejected Arena Pharmaceuticals, Inc. (ARNA), Eisai Company, Ltd. (ESALY.PK) Obesity Drug, Lorcaserin Shows Success In Diabetes Patients, but Increases Heart Risk for Obese Diabetics
11/9/2010
More...
|
Roche (RHHBY)'s Genentech (RHHBY) and Plexxikon Inc.'s Melanoma Drug Shows Promise In Phase II Study
11/5/2010
More...
|
MacroGenics, Inc. and Eli Lilly and Company (LLY) Announce Pivotal Clinical Trial of Diabetes Drug Teplizumab Did Not Meet Primary Efficacy Endpoint
10/22/2010
More...
|
Phase II Study with Genentech (RHHBY) and Biogen Idec, Inc. (Massachusetts) (BIIB)'s Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis Patients
10/15/2010
More...
|
AVI BioPharma, Inc. (AVII) Says MD Drug, AVI-4658 Does Well in Test
10/15/2010
More...
|
Johnson & Johnson (JNJ) Drug Abiraterone for Prostate Cancer Extends Life in Phase III Study
10/11/2010
More...
|
Seattle Genetics, Inc. (SGEN)' Second Brentuximab Trial for Lymphoma Succeeds
10/11/2010
More...
|
Seattle Genetics, Inc. (SGEN), Millennium: The Takeda Oncology Company Drug SGN-35 Shrinks Lymphoma Patients' Tumors in Study
9/29/2010
More...
|
Sanofi-Aventis (France) (SASY.PA), Vical Incorporated (VICL) Limb Ischemia Drug NV1FGF Fails in Late-Stage Test
9/23/2010
More...
|
GlaxoSmithKline (GSK) Kidney Cancer Drug Shrinks Thyroid Tumors
9/20/2010
More...
|
Transition Therapeutics Inc. (TTH.TO) and Eli Lilly and Company (LLY) Stops Diabetes Drug Development
9/17/2010
More...
|
Idenix Pharmaceuticals, Inc. (IDIX) Hep C Drugs On Clinical Hold On Safety Concerns
9/7/2010
More...
|
Roche (RHHBY) And Plexxikon Inc. Melanoma Drug Works In 81 Pct Of Patients
8/26/2010
More...
|
Eli Lilly and Company (LLY) Halts Development Of Alzheimer's Drug
8/19/2010
More...
|
Amgen (AMGN) Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial; Vectibix Fails to Meet Primary Endpoint
8/12/2010
More...
|
Vertex Pharmaceuticals (MA) (VRTX) Hep C Drug Works In Half The Time of Current Therapy
8/11/2010
More...
|
In Pivotal Phase III Studies, Merck & Co., Inc. (MRK)'s Investigational Medicine Boceprevir Helped Majority of Patients with Chronic Hepatitis C Genotype 1 Infection Achieve Sustained Virologic Response, the Primary Endpoint of the Studies
8/4/2010
More...
|
Isis Pharmaceuticals, Inc. (ISIS), Genzyme Corporation (GENZ) Cholesterol Drug Meets Study Goals; Meet Primary Endpoints with 36 and 37 Percent LDL-C Reductions in Severe Hypercholesterolemia and High-Risk Patients
8/4/2010
More...
|
Orexigen Therapeutics, Inc. (OREX) Obesity Pill Shows Promise in Phase III Study; Stock Rises 9.47% at 1:20PM EDT
7/30/2010
More...
|
Toxicology Sinks Vernalis PLC (VNLPY.PK), Biogen Idec, Inc. (Massachusetts) (BIIB)'s Parkinson's Drug
7/28/2010
More...
|
Tibotec Pharmaceuticals Ltd Announces TMC278 Pivotal Phase 3 Clinical Trials Achieve Primary Objective
7/23/2010
More...
|
Gilead Sciences, Inc. (GILD) Release: Vaginal Gel Cuts HIV Infections While Blocking Herpes
7/21/2010
More...
|
Pfizer Inc. (PFE) Halts Tanezumab Studies For Back Pain, Diabetes
7/21/2010
More...
|
GlaxoSmithKline (GSK) And XenoPort, Inc. (XNPT) Migraine Drug Fails Mid-stage Trial: No Improvement For GSK1838262/XP13512 Vs Placebo
7/7/2010
More...
|
Bayer HealthCare Pharmaceuticals (BAYA.F), Onyx Pharmaceuticals, Inc. (ONXX)'s Nexavar Fails Phase III Lung Cancer Trial
6/14/2010
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Data From Phase 2 Clinical Program of Voreloxin in Acute Myeloid Leukemia Support Phase 3 Trial in Relapsed or Refractory Patients
6/8/2010
More...
|
Amgen (AMGN) Denosumab Demonstrated Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Prostate Cancer
6/7/2010
More...
|
Celgene International Sárl (CELG) Release: Oral Presentation at American Society of Clinical Oncology from Intergroup Phase III Study (CALGB 100104) Evaluates Continuous REVLIMID® in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant
6/7/2010
More...
|
Skin Cancer Drug, Ipilimumab News Boosts Bristol-Myers Squibb Company (BMY) Shares
6/7/2010
More...
|
Celgene Corporation (CELG) Release: At American Society of Clinical Oncology, Oral Presentation from Intergroupe Francophone Du Myelome (IFM) of Phase III Study (IFM 2005 02) Evaluating Continuous REVLIMID® in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant
6/7/2010
More...
|
Nektar Therapeutics (NKTR) Ovarian Cancer Drug Benefits Women in Study
6/7/2010
More...
|
Celldex Therapeutics, Inc. (CLDX) Shares Fall Following Study Update; Celldex Called Buying Opportunity After Data Snafu
5/21/2010
More...
|
Amgen (AMGN) Drug Shows Promise In Ovarian Cancer
5/21/2010
More...
|
Roche (RHHBY) and Biogen Idec, Inc. (Massachusetts) (BIIB) Announce Decision to Discontinue Phase 3 Ocrelizumab Clinical Development Program in Patients with Rheumatoid Arthritis
5/19/2010
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Says Lou Gehrig's Disease Drug Fails In Study
5/17/2010
More...
|
GlaxoSmithKline (GSK)'s 'Red Wine' Drug Trial Halted Over Safety Concerns
5/5/2010
More...
|
Bristol-Myers Squibb Company (BMY) Compound Potent Against Hepatitis C
4/22/2010
More...
|
Delcath Systems, Inc. (DCTH) Says Late-Stage Cancer Trial Meets Main Goal
4/22/2010
More...
|
InterMune, Inc. (ITMN) Reports Top-Line Results From Phase 2b Study of Danoprevir (RG7227/ITMN-191) in Patients with Chronic Hepatitis C
4/14/2010
More...
|
Molecular Insight Pharmaceuticals, Inc. (MIPI) Mid-stage Cancer Drug, Onalta Trial Positive
4/13/2010
More...
|
ArQule, Inc. (ARQL) Soars On Positive Lung Cancer Drug Phase 2 Trial
3/31/2010
More...
|
Vernalis PLC (VNLS) Dives as Pain Drug Fails Clinical Test; V3381 Misses Primary Endpoint in Neuropathic Pain
3/24/2010
More...
|
Abraxis BioScience, Inc.: ABRAXANE Meets Primary Endpoint in Phase 3 Trial for Advanced Non-Small Cell Lung Cancer
3/17/2010
More...
|
Human Genome Sciences, Inc. (HGSI) Lung Cancer Drug, Mapatumumab in Combination with Chemotherapy Agents Fails to Improve Survival
3/17/2010
More...
|
Pfizer Inc. (PFE) (JOBS) Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
3/12/2010
More...
|
Roche (RHHBY), Genentech (RHHBY)'s Avastin Fails in Prostate Cancer Study
3/12/2010
More...
|
AstraZeneca PLC (AZN)'s (JOBS) Recentin Fails Phase 3 Trial, Hurts Shares
3/8/2010
More...
|
Medivation, Inc. (MDVN)(JOBS), Pfizer Inc. (PFE) (JOBS) Drug Dimebon Fails Phase 3 Alzheimer's Study
3/3/2010
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) Reports Positive LibiGel(R) Safety Data in Phase III Program
2/22/2010
More...
|
Gilead Sciences, Inc. (GILD)'s Single-Tablet "Quad" Regimen for HIV Achieves a High Rate of Virologic Suppression in Phase II Study
2/18/2010
More...
|
Regeneron Pharmaceuticals, Inc. (REGN), Bayer HealthCare (BAY) Say Eye Drug Meets Mid-stage Goal
2/18/2010
More...
|
Isis Pharmaceuticals, Inc. (ISIS) (JOBS) Says Cholesterol Drug Works; But Safety Weighs
2/11/2010
More...
|
Amgen (AMGN) (JOBS): Denosumab Prostate Cancer Trial Meets Goals
2/9/2010
More...
|